Edesa Biotech, Inc. (EDSA)
4.84
+0.08
(+1.68%)
USD |
NASDAQ |
Sep 03, 15:05
Edesa Biotech Market Cap : 46.62M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 02, 2026 | 45.85M |
| September 01, 2026 | 46.05M |
| August 31, 2026 | 45.61M |
| August 28, 2026 | 44.51M |
| August 27, 2026 | 44.31M |
| August 26, 2026 | 47.59M |
| August 25, 2026 | 42.87M |
| August 24, 2026 | 42.39M |
| August 21, 2026 | 42.68M |
| August 20, 2026 | 45.85M |
| August 19, 2026 | 55.39M |
| August 18, 2026 | 55.01M |
| August 17, 2026 | 54.43M |
| August 14, 2026 | 51.54M |
| August 13, 2026 | 52.31M |
| August 12, 2026 | 51.06M |
| August 11, 2026 | 53.18M |
| August 10, 2026 | 46.56M |
| August 07, 2026 | 46.83M |
| August 06, 2026 | 44.87M |
| August 05, 2026 | 45.94M |
| August 04, 2026 | 47.63M |
| August 03, 2026 | 46.47M |
| July 31, 2026 | 45.41M |
| July 30, 2026 | 46.65M |
| Date | Value |
|---|---|
| July 29, 2026 | 47.63M |
| July 28, 2026 | 44.16M |
| July 27, 2026 | 47.54M |
| July 24, 2026 | 46.65M |
| July 23, 2026 | 50.29M |
| July 22, 2026 | 50.47M |
| July 21, 2026 | 53.58M |
| July 20, 2026 | 51.71M |
| July 17, 2026 | 58.65M |
| July 16, 2026 | 59.71M |
| July 15, 2026 | 61.04M |
| July 14, 2026 | 59.89M |
| July 13, 2026 | 60.51M |
| July 10, 2026 | 62.29M |
| July 09, 2026 | 62.38M |
| July 08, 2026 | 64.95M |
| July 07, 2026 | 64.87M |
| July 06, 2026 | 64.07M |
| July 02, 2026 | 66.64M |
| July 01, 2026 | 68.86M |
| June 30, 2026 | 72.24M |
| June 29, 2026 | 68.15M |
| June 26, 2026 | 72.77M |
| June 25, 2026 | 66.38M |
| June 24, 2026 | 70.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProMIS Neurosciences, Inc. | 114.52M |
| Arrowhead Pharmaceuticals, Inc. | 12.11B |
| Oncolytics Biotech, Inc. | 106.57M |
| Sangamo Therapeutics, Inc. | 70.84M |
| Sarepta Therapeutics, Inc. | 2.431B |
Market Cap Related Metrics
| PEG Ratio | -0.1046 |
| Price to Book Value | 116.85 |
| Price | 4.84 |
| Earnings Yield | -34.95% |
| PEGY Ratio | -0.1046 |